Wang LiXia, Wang FaPing, Yang Chuan, Luo FengMing
Department of Respiratory and Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, China.
Laboratory of Pulmonary Immunology and Inflammation, Frontiers Science Center for Disease-related Molecular Network, Sichuan University, Chengdu, China.
Front Neurol. 2022 Sep 1;13:908086. doi: 10.3389/fneur.2022.908086. eCollection 2022.
is a rapidly growing mycobacterium (RGM) that belongs to the unnamed third biovariant complex of the group, which is rarely responsible for human infection. Approximately 76% of infections caused by the group occur after open fractures or skin, soft tissue, bone, or puncture wounds. To date, only a few cases of human infectious disease caused b have been reported worldwide.
We present a case of a 26-year-old man with a central nervous system (CNS) infection caused by . The patient was transferred to our hospital because of headaches and muscle strength changes. One month prior to presentation at our hospital, the patient was diagnosed with tuberculous meningitis at the other two hospitals, but his condition did not improve after anti-tuberculous treatment, antibiotics, and anti-viral treatment before admission to our hospital. Lumbar puncture was performed at both previous hospitals, as well as at our hospital; the results consistently indicated high cerebrospinal fluid (CSF) opening pressure. was detected in the CSF of the second hospital's lumbar puncture by metagenomic next-generation sequencing (mNGS) but was not identified at our hospital. The patient was discharged from our hospital after receiving non-tuberculous mycobacterium (NTM) treatment for 1 month according to the Chinese NTM guidelines. However, the patient died 20 days after discharge.
Since it is difficult to identify , this is the first case of human CNS infection caused by in China. This case may be considered by neurologists and infectious physicians when CNS infection does not respond to conventional treatment, especially in the uncommon type of NTM.
[病原体名称]是一种快速生长的分枝杆菌(RGM),属于[菌属名称]未命名的第三个生物变种复合体,很少引起人类感染。[菌属名称]引起的感染约76%发生在开放性骨折或皮肤、软组织、骨骼或穿刺伤之后。迄今为止,全球仅报告了少数几例由[病原体名称]引起的人类传染病病例。
我们报告一例26岁男性由[病原体名称]引起的中枢神经系统(CNS)感染病例。患者因头痛和肌力变化被转诊至我院。在我院就诊前一个月,患者在另外两家医院被诊断为结核性脑膜炎,但在入院前接受抗结核治疗、抗生素和抗病毒治疗后病情并未改善。之前两家医院以及我院均进行了腰椎穿刺;结果均显示脑脊液(CSF)初压较高。通过宏基因组下一代测序(mNGS)在第二家医院腰椎穿刺的CSF中检测到了[病原体名称],但在我院未检测到。根据中国非结核分枝杆菌(NTM)诊疗指南,患者接受NTM治疗1个月后从我院出院。然而,患者出院20天后死亡。
由于[病原体名称]难以识别,这是中国首例由[病原体名称]引起的人类CNS感染病例。当中枢神经系统感染对常规治疗无反应时,尤其是对于罕见类型的NTM,神经科医生和感染科医生应考虑到该病例。